HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.
August 11th 2022
Experts in blood disorders share the importance of managing red blood cell health and optimal approaches and unmet needs in the management of sickle cell disease.
July 28th 2022
Experts in dermatology discuss treatment considerations for pediatric patients with atopic dermatitis and highlight emerging therapeutics andthe role they are likely to play in the future treatment of this condition.
July 26th 2022
Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.
June 30th 2022
A multidisciplinary panel of experts explores recent advances in the management of opioid induced constipation.
June 24th 2022
Retina specialists explore the practical and clinical implications of the rapidly developing treatment spectrum for diabetic macular edema and age-related macular degeneration.
May 31st 2022
Experts in pediatric hepatology share considerations for the diagnosis of Alagille syndrome and explore strategies for optimizing treatment.
Expert gastroenterologists examine the sequencing of therapies and optimizing treatment selection in the evolving treatment landscape for ulcerative colitis.
April 29th 2022
Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.
A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.
April 27th 2022
Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.
IBS Prevalence High Among Veterans
Long-Term Effectiveness of Adalimumab Reported in Patients with Noninfectious Uveitis
Biologic Agents May Reduce Risk of Mental Health Disorders in Some Patients with Psoriasis